Ovarian cancer patients given fresh hope thanks to double drug treatment

Ruth Joy (pictured), from West Sussex, was diagnosed with advanced, slow-growing ovarian cancer in 2006. She has benefitted from a clinical trial involving MEK inhibitors and defactinib.

from Health News | Mail Online https://ift.tt/3k8Yvzq

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home